These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11118308)

  • 1. Bioluminescent Mycobacterium aurum expressing firefly luciferase for rapid and high throughput screening of antimycobacterial drugs in vitro and in infected macrophages.
    Deb DK; Srivastava KK; Srivastava R; Srivastava BS
    Biochem Biophys Res Commun; 2000 Dec; 279(2):457-61. PubMed ID: 11118308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Mycobacterium aurum expressing Escherichia coli beta-galactosidase in high throughput screening of antituberculosis drugs.
    Srivastava R; Kumar D; Srivastava BS
    Biochem Biophys Res Commun; 1997 Nov; 240(3):536-9. PubMed ID: 9398599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Green fluorescent protein as a reporter in rapid screening of antituberculosis compounds in vitro and in macrophages.
    Srivastava R; Deb DK; Srivastava KK; Locht C; Srivastava BS
    Biochem Biophys Res Commun; 1998 Dec; 253(2):431-6. PubMed ID: 9878553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Galactosidase reporter system in mycobacteria and its application in rapid antimycobacterial drug screening.
    Srivastava R; Kumar D; Subramaniam P; Srivastava BS
    Biochem Biophys Res Commun; 1997 Jun; 235(3):602-5. PubMed ID: 9207204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery.
    Arain TM; Resconi AE; Hickey MJ; Stover CK
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1536-41. PubMed ID: 8726034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
    Bhusal Y; Shiohira CM; Yamane N
    Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reporter gene technology to assess activity of antimycobacterial agents in macrophages.
    Arain TM; Resconi AE; Singh DC; Stover CK
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1542-4. PubMed ID: 8726035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB.
    El-Sayed Zaki M; Goda T
    Tuberculosis (Edinb); 2007 Mar; 87(2):102-8. PubMed ID: 17035089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Mycobacterium tuberculosis activities of new fluoroquinolones in combination with other antituberculous drugs.
    Tomioka H; Sato K; Shimizu T; Sano C
    J Infect; 2002 Apr; 44(3):160-5. PubMed ID: 12099742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Green fluorescent protein reporter microplate assay for high-throughput screening of compounds against Mycobacterium tuberculosis.
    Collins LA; Torrero MN; Franzblau SG
    Antimicrob Agents Chemother; 1998 Feb; 42(2):344-7. PubMed ID: 9527783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T; Drlica K
    J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential use of nitrate reductase as a biomarker for the identification of active and dormant inhibitors of Mycobacterium tuberculosis in a THP1 infection model.
    Sarkar S; Sarkar D
    J Biomol Screen; 2012 Aug; 17(7):966-73. PubMed ID: 22573731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establishment and drug susceptibility test of isoniazid resistant Mycobacterium smegmatis].
    Jia PP; Zhao LL; Li XY; Zhang Q; Liu ZL; Wang X; Yu LY; Zhao LX; Cen S
    Yao Xue Xue Bao; 2011 Apr; 46(4):377-82. PubMed ID: 21751489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimicrobial susceptibility testing for Mycobacterium tuberculosis by measuring mycobacterial adenosine triphosphate].
    Yamazaki T; Sato N; Yamashita K; Okazawa Y; Miyao H; Tanno K
    Rinsho Byori; 1999 Feb; 47(2):170-5. PubMed ID: 10097635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence.
    Andreu N; Fletcher T; Krishnan N; Wiles S; Robertson BD
    J Antimicrob Chemother; 2012 Feb; 67(2):404-14. PubMed ID: 22101217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro antimycobacterial activity of a new quinolone, NM394].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1993 Aug; 68(8):517-20. PubMed ID: 8397311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages.
    Jacobs WR; Barletta RG; Udani R; Chan J; Kalkut G; Sosne G; Kieser T; Sarkis GJ; Hatfull GF; Bloom BR
    Science; 1993 May; 260(5109):819-22. PubMed ID: 8484123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A whole blood bactericidal assay for tuberculosis.
    Wallis RS; Palaci M; Vinhas S; Hise AG; Ribeiro FC; Landen K; Cheon SH; Song HY; Phillips M; Dietze R; Ellner JJ
    J Infect Dis; 2001 Apr; 183(8):1300-3. PubMed ID: 11262217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
    Matsuoka M; Kashiwabara Y; Namisato M
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a bioluminescent mycobacterium and its use for assay of antimycobacterial agents.
    Andrew PW; Roberts IS
    J Clin Microbiol; 1993 Sep; 31(9):2251-4. PubMed ID: 8408541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.